The Epsilon Group

The Epsilon Group is a private healthcare modeling, analytics, and simulation company focused on diabetes and related metabolic disease. The company provides in silico software platforms and consulting services that support translational research, device development, protocol optimization, and virtual clinical studies, rather than developing therapeutic drugs itself. Its core commercial products are the Type 1 Diabetes Metabolic Simulator (T1DMS) and Diabetes Mellitus Metabolic Simulator for Research (DMMS.R), which are used by academic and commercial groups to model glucose-insulin metabolism in Type 1 diabetes, Type 2 diabetes, and prediabetes. The company also supports life sciences and pharma customers with PK/PD-oriented modeling, dose and protocol optimization, and diabetes device simulation, including work aligned with FDA regulatory expectations. Overall, The Epsilon Group is best characterized as a specialized health technology and disease-modeling company serving diabetes R&D, medical device, and translational research markets.